Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS).

Key steps to bring ADCs successfully to clinical trial

The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer treatments by enabling more precise targeting of cancerogenic cells.

GELITA launches Endotoxin Controlled Excipients for bioscience applications

GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch of its Endotoxin Controlled Excipients (ECE) portfolio.[1] This cutting-edge product line, featuring VACCIPRO® and MEDELLAPRO®.

Astorg Continues to Bolster its Newly Combined Global Leader in Assisted Reproductive Technology by Acquiring FUJIFILM Irvine Scientific's Medical Media Business

Following Astorg’s recent take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business (“Cook Medical RH”), the newly combined global leader in assisted reproductive technology (ART).

Swiss Airtainer reaches major milestone with successful completion of first 50 commercial shipments

Swiss Airtainer is pleased to announce the successful completion of its first 50 commercial shipments of high-value life science products. These shipments have demonstrated the performance, sustainability, and cost-efficiency of Swiss Airtainers.